BNTC Benitec Biopharma Limited

2.13
+0.02  (1%)
Previous Close 2.11
Open 2.09
Price To book 1.14
Market Cap 21847700
Shares 10,257,136
Volume 14,534
Short Ratio 4.45
Av. Daily Volume 21,081

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial to be initiated early 2018.
BB-401
Head and neck squamous cell carcinoma
Announced late February 2016 plans to discontinue development
TT-034
Hepatitis C